Bentham Science Logo

Track Your Manuscript:


Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 10 - Number 3








Metabolic Acidosis in Sepsis

, 10(3): 252 - 257

Alexandre Toledo Maciel, Danilo Teixeira Noritomi and Marcelo Park


DOI: 10.2174/187153010791936900


Lipid-Activated Nuclear Receptors and Sepsis

, 10(3): 258 - 265

Thais Martins de Lima-Salgado, Luiz Monteiro Cruz and Heraldo Possolo Souza


DOI: 10.2174/187153010791936937


Corticosteroids in Sepsis: Pathophysiological Rationale and the Selection of Patients

, 10(3): 266 - 273

Jorge Ibrain Figueira Salluh, Fernando Augusto Bozza, Andre Miguel Japiassu, Hugo Caire Castro Faria Neto, Patricia Torres Bozza and Pedro Povoa


DOI: 10.2174/187153010791936865






Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Scopus CiteScore Metrics: 1.79

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi


Advertisement

MANAGING MEDICAL WRITINGCovid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog